PROXIQUANT

Welcome to the Brand page for “PROXIQUANT”, which is offered here for Nucleic acid reagents for use in clinical and research applications;.

Its status is currently believed to be active. Its class is unavailable. “PROXIQUANT” is believed to be currently owned by “International Therapeutics, Inc.”

Owner:
INTERNATIONAL THERAPEUTICS, INC.
Owner Details
Description:
Nucleic acid reagents for use in clinical and research applications;
Categories: NUCLEIC ACID REAGENTS USE